PROS1 and COVID-19: This finding suggests that individuals with prior COVID-19 exposure might exhibit a more pronounced coagulation response after the first vaccine dose, possibly due to a more robust immune response triggered by the recognition of the SARS-CoV-2 S protein in the vaccine.